Clinical and Genetic Factors on the Postoperative Recovery Time of General Anaesthesia
1 other identifier
observational
1,453
1 country
1
Brief Summary
To evaluate the effect of clinical factors on the recovery time of postoperative anesthesia and the effect of genetic variation in gDNA on the recovery time of postoperative anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 30, 2016
CompletedFirst Posted
Study publicly available on registry
July 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedJuly 10, 2018
July 1, 2018
1.4 years
June 30, 2016
July 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recover time of anesthesia
within 24 hours
Study Arms (1)
patients after general anesthesia
Laparoscopic surgery, orthopedics surgery or open surgery patients after general anesthesia
Eligibility Criteria
Laparoscopic surgery, orthopedics surgery or open surgery patients in Chinese
You may qualify if:
- Aged more than 18 years;
- General anesthesia for all patients;
- Patients underwent surgery for laparoscopic surgery, orthopedics surgery or open surgery;
- Patients were not delivered allogeneic blood in three months;
- Having the ability to understand and sign the informed consent.
You may not qualify if:
- Pregnant or lactating women;
- Having an immune deficiency, as a patient with HIV infection;
- Patients with infectious diseases, such as syphilis;
- Patients delivered allogeneic blood in three months;
- Researchers believe that may increasing the risk of subjects or interfering clinical trial;
- Don't have the ability to understand or sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yijing Helead
Study Sites (1)
Xiangya Hospital Central South University
Changsha, Hunan, 410008, China
Biospecimen
Samples with DNA retain 1 year
Study Officials
- PRINCIPAL INVESTIGATOR
Yijing He, MD,PhD
Xiangya Hospital of Central South University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
June 30, 2016
First Posted
July 4, 2016
Study Start
June 1, 2016
Primary Completion
October 10, 2017
Study Completion
December 31, 2017
Last Updated
July 10, 2018
Record last verified: 2018-07